Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Neural correlates and behavioral outcomes of aesthetic chills and their prosthetic augmentationPsyArXiv · 2026-09-13A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.Journal of clinical psychology · 2026-09-01Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.Clinical therapeutics · 2026-08-01Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.medRxiv: the preprint server for health sciences · 2026-07-14Surprising Variability in Tryptamine Profiles of Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions.Journal of fungi (Basel, Switzerland) · 2026-07-02Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-03-01Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-12Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.Journal of psychopharmacology (Oxford, England) · 2026-01-01The genus Psilocybe in ItalyItalian Botanist · 2025-12-22Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-12-09Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-11-21Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-02Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.Molecular neurobiology · 2025-11-01Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping ReviewPreprints.org · 2025-10-17Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A ReviewCurr Microbiol · 2025-09-01A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy (Chicago, Ill.) · 2025-09-01Selective Phosphorylation of Phenols and Benzenediols by the Kinase PsiK and Variants Thereof.Angewandte Chemie (International ed. in English) · 2025-08-18Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.Current microbiology · 2025-07-15Psilocybin treatment extends cellular lifespan and improves survival of aged mice.npj aging · 2025-07-08Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report.BMC psychiatry · 2025-02-28Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2025-01-01Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathwaysbioRxiv · 2024-12-17An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United StatesPsychedelics. · 2024-09-13Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.Clinical case reports · 2024-09-01Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.Current neurology and neuroscience reports · 2024-08-01Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.Journal of psychopharmacology (Oxford, England) · 2024-05-01Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.Ageing research reviews · 2024-04-01Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.Frontiers in psychiatry · 2024-01-01Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data.Journal of psychoactive drugs · 2024-01-01Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depressionResearch Square · 2023-12-28Neuroimaging in psychedelic drug development: past, present, and future.Molecular psychiatry · 2023-09-01Psilocybin's Emerging Role in Combating Depressive DisorderJournal of Education Health and Sport · 2023-08-08The need for establishing best practices and gold standards in psychedelic medicine.Journal of affective disorders · 2023-07-01New Pharmacologic Approaches to the Treatment of Bipolar Depression.Drugs · 2023-07-01Psilocybin decelerates cellular senescenceResearch Square · 2023-06-27Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics.Neurotrauma reports · 2023-01-01The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness.Journal of psychoactive drugs · 2023-01-01Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.Frontiers in psychiatry · 2023-01-01Psychedelics, epilepsy, and seizures: a review.Frontiers in pharmacology · 2023-01-01A Review of Synthetic Access to Therapeutic Compounds Extracted from.Pharmaceuticals (Basel, Switzerland) · 2022-12-28Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic PerspectiveIndian Journal of Forensic Medicine & Toxicology · 2022-10-10Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.Cureus · 2022-05-01The association between naturalistic use of psychedelics and co-occurring substance use disorders.Frontiers in psychiatry · 2022-01-01Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.PloS one · 2020-01-01P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocinEuropean Neuropsychopharmacology · 2014-03-01Exposure to Potent Hallucinogens in an AdolescentThe Primary Care Companion For CNS Disorders · 2013-10-23Psilocybin-induced stimulus control in the rat.Pharmacology, biochemistry, and behavior · 2007-10-01Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2003-01-015-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.Pharmacology, biochemistry, and behavior · 2002-05-01[PSYCHOMIMETIC SUBSTANCES. (CONTRIBUTION TO THE CLINICAL PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN)].Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali · 1963-09-30